Select your timezone:
Advanced Search
No podium presentations / lectures found ...

E-Posters Search Results

Poster Session: Allied Health
P1.01 Optimizing lung function during donor management through a multidisciplinary approach
Elizabeth Shipman, United States
P1.02 Training and Social Awareness targeted for Allied Health professionals for Increasing Organ Donation in The European Union and neighboring Countries: EUDONORGAN
Carmen Blanco, Spain
P1.03 Knowledge exchange program to increase the organ donation rates in Saudi Arabia
Marti Manyalich, Spain
P1.04 Biovigilance - Implementation of a tool for notification of adverse events in cells, organs and tissues in a country in South America.
Bartira B De Aguiar Roza A.R, Brazil
P1.05 Gender and transplantation. The impact of the social role of gender and its implications in the process of health-illness and care
Graciela V. Gambina, Argentina
P1.06 Exploration of the influencing factors of the self-management in renal transplant recipients based on the health promotion model
Hongxia Liu, People's Republic of China
P1.07 A new intervention to increase medication adherence in kidney transplant recipients: investigation of effect of SystemCHANGE intervention
Yaprak Sarıgöl Ordin, Turkey
Poster Session: Basic and Translational Science
P2.01 IL-33/ST2 signaling pathway: preliminary study to assess its role in chronic rejection after liver transplant
Maria Virginia Gentilini, Argentina
P2.02 Save the Environment: Liver Transplantation Restores a Circulating Environment that Supports Healthy Platelet Aggregation within Two Hours of Reperfusion
Hillary Braun, United States
P2.03 Dynamic kidney rejection risk prediction using serial donor derived cell free DNA
John Friedewald, United States
P2.04 Polymorphisms rs1800469, rs1800471 of the TGFB1 gene detected in patients with chronic heart failure who waiting cardiac transplantation
Olga Gichkun, Russian Federation
P2.05 Influence of adding calcium channel blocker Verapamil during perfusion for functioning transplanted kidney within 36 months after transplantation (mid term results)
Maciej Nowacki, Poland
P2.06 A survey of transplant recipient attitudes regarding contraception and pregnancy
Deirdre Sawinski, United States
P2.07 Asxl1 may promote the differentiation and function of Th17 cells
Puxun Tian, People's Republic of China
P2.08 Evaluation and maintenance of donor liver quality in rats from donated after cardiac death by hypothermic oxygenated machine perfusion and cold storage
Fu Zhen, People's Republic of China
P2.11 Distinct global DNA methylation and NF-κB expression profile of preimplantation biopsies from ideal and non-ideal kidneys
Mario Abbud-Filho Sr., Brazil
P2.13 Immunosuppression monotherapy does not protect donor leukocytes from depletion post MHC-mismatched kidney transplantation in mice.
Sarah Dart, Australia
P2.14 Accelerating the differentiation of Neonatal porcine pancreatic cell clusters into beta cells in alginate-microcapsules.
Heon-Seok Park, Korea
P2.15 A positive b2 microglobulin trend immediately after transplant identify worse outcomes in patients with delayed graft function
Angelica Perez-Gutierrez, United States
P2.17 Retrograde reperfusion of the renal graft in adult recipient to reduce ischemia-reperfusion injury
Myltykbay Rysmakhanov, Kazakhstan
P2.18 Local immune cells' phenotype after corneal graft rejection
Justyna Sakowska, Poland
P2.19 Role of the intestinal microbiota in the course of chronic liver disease before and after liver transplantation results of a pilot study
Umid Ravshanovich Salimov, Belarus
P2.20 Angiogenesis promoting effects of human amnion membrane in ischemia-impaired wound in a rat model
Kazuaki Tokodai, Japan
P2.21 Protection of normal metabolic function of healthy pig livers following prolonged normothermic ex-situ perfusion
Jordi Vengohechea Llorens, Spain
Poster Session: Bone Marrow
P3.01 Similar graft-versus-host disease (GVHD) incidence among unrelated and identical sibling donor transplantation with the use of anti-thymocyte globulin (ATG)
Agustina Cia, Argentina
P3.02 Assessment of chimerism testing by next generation sequencing
Mohamed Elrefaei, United States
P3.03 Allogeneic hematopoietic stem cells transplantation (AHSCT). Is still the sibling donor the best option? One single center experience
Nicolas Fernandez Escobar Sr., Argentina
P3.04 Apraglutide Treatment Reduces Chemotherapy-induced Gastrointestinal (GI) Damage in Mice and Preserves Cellular Integrity
Violetta Dimitriadou, Switzerland
P3.05 Apraglutide Decreases Severity of Intestinal Damage from Gastrointestinal (GI) Acute Graft-Versus-Host-Disease (GvHD) Following Allogeneic Transplantation Without Impacting Engraftment
Violetta Dimitriadou, Switzerland
P3.06 Apraglutide Does Not Impact Anti-tumor and Immunosuppressive Efficacy of Conditioning Chemotherapy in Mice
Violetta Dimitriadou, Switzerland
P3.07 Treatment with Apraglutide Preserves the Global Homeostatic Environment of Intestinal Microbiota During Chemotherapy in Mice
Violetta Dimitriadou, Switzerland
Poster Session: Critical Care and Anesthesia
P4.01 Searching new donation scenarios: potencial receptors "on the other side of the mirror"
Paula Rivera Sánchez, Spain
P4.02 Performance of the Hypotension Prediction Index in living donor liver transplant recipients: a prospective observational study
Seong Mi Yang, Korea
P4.03 Anesthetic management of a glycogen storage disease type 1a with air embolism during liver transplantation: a case report
Emre Kandemir, Turkey
Poster Session: Education
P5.01 Belt & Road Organ Donation Capacity Improvement Cooperation Training Project (BROAOD)
Chloë Ballesté, Spain
P5.02 Impacts on NHS renal transplant educational service delivery during the covid-19 global pandemic
John Black, United Kingdom
P5.03 Teaching the new medical specialties: Transplant, the challenge of accompanying scientific progress from education.
Maria del Carmen Bacque, Argentina
P5.04 Knowledge about donation and transplantation in the health team
Maria del Carmen Bacque, Argentina
P5.05 Development of a multidisciplinary protocol for thoracic organ donation process
Luiz Gustavo Torres Dias da Cruz, Brazil
P5.06 Health Professional Education
Battsetseg Gonchigjav, Mongolia
P5.07 Impact of the Liver Transplant Pharmacy (LTP) at the Center for Liver Transplant and Hepatobiliary Surgery (CLTHPS) in educating our transplanted patients in Costa Rica. A comparison of benefits to a traditional model pharmacy
Carlos Castro-Benitez, Costa Rica
P5.10 Cognitive profile and educational trajectory in adolescents and young adults with liver transplants at the Garrahan pediatrics hospital
Lucia Bourdieu Yrujo, Argentina
P5.11 Education in the donation-transplant process in undergraduate medical training
Marisa M. Cobos, Argentina
P5.12 Education of medical students on organ donation and transplantation
Viktor Denisov, Ukraine
P5.13 Developing a standardized education program on deceased organ donation for pre-medical students
Hee Jung Jeon, Korea
P5.14 Quality appraisal of evidence-based guidelines for the health education of solid organ transplantation
Jing Sun, People's Republic of China
P5.15 Build-up on school education program to nurture the value of sharing and deceased organ donation for youth in Korea
Jieun Oh, Korea
P5.16 Learning from the learning curve: the personal database of an entry-level transplant surgeon as a tool to improve outcomes
Alex Zendel, United States
Poster Session: Ethics and Transplantation
P6.01 Actuarial Perspective on the Immunosuppressive Medication Costs and Coverage for Transplant Recipients in the Argentine´s Public System: 2009-2021
Ignacio Drake, Argentina
P6.02 Provisional and promising bioethical conclusions on uterine transplantation
Elian Pregno, Argentina
P6.03 Traumatic events and treatment non-adherence: a potential association?
Daniel Osvaldo O Merino, Argentina
P6.04 Xenotransplantation and Bioethics
Roberto Cambariere, Argentina
P6.05 Depression and suicide in end stage kidney disease (on dialysis and kidney transplant recipients): A national-wide population study.
Jun Young Lee, Korea
P6.06 The monetary cost of delays in kidney transplantation in a public health facility in a developing country:Kenyan experience.
John Ngigi, Kenya
P6.07 Risk factors for trauma death among transplant recipients
Alejandro C Chiodo Ortiz, United States
P6.08 Questions about xenotransplantation in ethical and religious literature
Boris I Yaremin, Russian Federation
P6.09 Extended Criteria Donor, Cold Ischemia Time and Delayed Graft Functions; common ingredients for an expensive recipe.
Mohamed H Zahran, Egypt
Poster Session: Intestinal Transplantation
P7.01 Selecting candidates for multi-visceral transplantation in neuroendocrine tumors (NET) of the gastrointestinal tract; A review of two cases
Peyman Arasteh, Iran (Islamic Republic of)
P7.02 Parenteral nutrition free survival in pediatric patients with short bowel syndrome: transplantation vs. serial transverse enteroplasty (STEP), a paired matched case-control study
Gimena V Galdeano, Argentina
P7.03 Analysis of immune cells draining from the abdominal cavity as a novel tool to early prediction of clinical events. Prospective multicenter study - INIGMA follow-up report
Maria Virginia Gentilini, Argentina
P7.04 A case of multivisceral transplantation in a patient with diffuse portal thrombosis, budd-chiari syndrome, previous portal-ivc shunt thrombosis and dalteparin allergy
Carmelo Loinaz, Spain
P7.05 Current challenges to starting an intestinal transplant program in the world today: Perspectives from emerging economy
Hamed Nikoupour, Iran (Islamic Republic of)
P7.06 Endovascular thrombectomy in a chronic upper cava syndrome due to long term home parenteral nutrition. New hope to extend life support.
Camila Caceres, Argentina
P7.07 Thyroid infection caused by invasive aspergillosis in solid organ transplantation: a case report
Hector Solar, Argentina
P7.08 Intestinal transplantation in a country without home parenteral nutrition; the largest report from the middle east
Pooya Vatankhah, Iran (Islamic Republic of)
P7.09 Population Model Confirms Predictable Pharmacokinetic (PK) and Pharmacodynamic (PD) Profile for Apraglutide: Data from Two Randomized Phase 1 Studies
Gerard Greig, Switzerland
P7.10 A Phase 1, Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects with Normal and Impaired Renal Function
Gerard Greig, Switzerland
Poster Session: Kidney
P8.001 Robotic-assisted living donor nephrectomy: high technology incorporated for patient benefit
Phillipe Abreu, United States
P8.002 Cholelithiasis: Should we be more Aggressive in Transplant Patients?
Phillipe Abreu, United States
P8.003 Post-transplant diabetes de NOVO (NODAT) in a Paraguayan kidney transplant population: prevalence and risk factors
Juan D Acosta Sr., Paraguay
P8.004 Kidney graft surveillance biopsies, histological findings and safety of the procedure
Maria Nieves I Aran, Argentina
P8.005 Collapsing glomerulopathy recurrence in a kidney transplant patient
Valeria Gabriela Alberton, Argentina
P8.005a (331.6 in the Journal) Impact of Left Ventricular Ejection Fraction and Previous Cardiac Revascularization on Kidney Transplant Recipient Outcomes
Dominic Amara, United States
P8.006 Urinary tract infections in kidney transplant. Treatment duration and recurrences : A Multicenter study in Argentina
Laura Barcan, Argentina
P8.007 Single Nuclei RNA-sequencing Unravels Complex Renal and Immune Cells Signaling Driving Fibrosis in Kidney Allografts
Jennifer McDaniels, United States
P8.008 Single Nuclei Profiling of Focal and Segmental Glomerulosclerosis from Human Allografts
Jennifer McDaniels, United States
P8.009 The association between atherosclerosis and intrarenal resistance index in kidney transplant recipients
Niels T. Bloemendal, Netherlands
P8.010 The association of Torque Teno viral (TTV) load with acute rejection and viral infections in the first-year post renal transplantation
Natalia Boccia, Argentina
P8.010a (342.10 in the Journal) IgA Nephropathy and Kidney Transplantation According to the Oxford Classification
Marcos Sousa, Brazil
P8.011 Urological complications and urinary tract infections depending on urinary outflow in pediatric patients after kidney transplantation
Dorota Broniszczak-Czyszek, Poland
P8.012 The impact of A Positive B-cell Flow Crossmatch in Living Donor Renal Transplant Recipients
Jorge M Chancay, United States
P8.013 Associations of circulating MicroRNAs (miR-21-5p, miR-20a-5p) and chronic allograft nephropathy in renal transplant recipients
Cheng-Hsu Chen, Taiwan
P8.015 Prevalence and risk factors associated with persistent hyperparathyroidism in kidney transplant recipients
Sofia Conci, Argentina
P8.016 Gram negative blood stream infection in renal transplant recipients: Risk factors and outcome from a transplant center in Pakistan
Sunil Kumar Dodani, Pakistan
P8.017 Post renal transplant malignancy: single center experience
Elizete EK Keitel MD, Brazil
P8.018 Human leukocyte antigen tissue typing in a Guatemalan transplant center
Karla O. Escobar, Guatemala
P8.019 Improving Access to Kidney Transplantation: Waitlisting and Kidney Transplantation in Southeastern Brazil
Gustavo Ferreira, Brazil
P8.020 Incidence and Correlates of Testicular Pain After Kidney Donation
Nisarg V Gandhi, United States
P8.021 Study the effect of sodium-glucose cotransporter-2 inhibition versus dipeptidyl peptidase-4 inhibition in diabetic kidney transplant recipients
Osama Ashry Gheith, Egypt
P8.022 Structured diabetes education: significance among kidney transplants recipients with post-transplant diabetes
Osama Ashry Gheith, Egypt
P8.023 Acute kidney injury among COVID-19 positive patients is associated with higher mortality: single center experience
Osama Ashry Gheith, Egypt
P8.024 Evaluation of function of angiopoietins and ANIOPOIETIN likes in post-transplantation diabetes mellitus (PTDM) in Kuwaiti kidney transplanted patients
Osama Ashry Gheith, Egypt
P8.025 Impact of full correction of post-transplant anemia on the cardiovascular system in renal transplant recipients receiving erythropoietin stimulating agents: prospective randomized controlled trial
Osama Ashry Gheith, Egypt
P8.026 Contrast-induced nephropathy in kidney transplant recipients: a single-center experience
Osama Ashry Gheith, Egypt
P8.027 Idiopathic polymyositis in renal transplant recipient: case report and review of literature
Osama Ashry Gheith, Egypt
P8.028 Impact of autophagy on the development of senescence in protocol biopsies in kidney transplant patients
Maria C. Giordani, Argentina
P8.029 Mini-flank donor nephrectomy incision: a single centre experience from Nigeria
Martin C. Igbokwe, Nigeria
P8.030 Post-kidney transplant prospective comparison of measured urinary creatinine clearance with estimated -eGFR based on serum creatinine or kinetic- KeGFR for rapid changes in serum creatinine
Ashokkumar B Jain, United States
P8.031 Outcome of simultaneous pancreas kidney transplantation a single center experience
George Kurian, India
P8.032 Post-transplant malignancy amongst kidney transplant recipients: A Single Centre 20-year Experience and literature review
George Kurian, India
P8.033 Teriparatide in kidney transplant patients with bisphosphonate-resistent osteoporosis
Luis Roberto Leon, Argentina
P8.034 Single Port Robotic versus Open Kidney Transplantation: A Comparison of Outcomes
Yi-Chia Lin, United States
P8.035 Early Recovery After Surgery Program in Kidney Transplantation Patients: Comparison of Clinical Outcomes with Conventional Care Program
Yi-Chia Lin, United States
P8.036 Late humoral rejection: will temporality be enough to determine the therapeutic attitude?
Luis Eduardo Morales Buenrostro, Mexico
P8.037 Changes in Body Composition after renal transplant in Children
Mara Medeiros, Mexico
P8.038 Prevalence of genetic mutations associated with kidney disorders in renal transplant recipients – single centre experience
Ankur Mittal, India
P8.039 Allele, genotype and haplotype frequencies of the HLA system in the province of Neuquén, Argentina.
Mariano Javier Navello, Argentina
P8.040 Vascular Surgeon in transplantation team, is there a room for such specialist?
Maciej Nowacki, Poland
P8.041 The gift of life and nonadherence in renal transplant recipients
Karly M Nygaard-Petersen, Canada
P8.042 Non-melanoma skin cancer with an aggressive course in kidney transplant patients treated with rapamycin.
Ana K Ochoa, Argentina
P8.043 Molluscum contagiosums as a cutaneous marker of immune reconstitution syndrome in a renal transplant patient
Ana K Ochoa, Argentina
P8.044 Factors contributing to acute rejection within one year of kidney transplantation with a perspective of Tacrolimus trough level; a nationwide cohort study
Cheol Woong Jung, Korea
P8.045 Modern Medicine Needs Modern Technology Tools
Zohreh S Soltani, United States
P8.046 Laparoscopic kidney transplantation: a minimally invasive alternative for our country
Francisco J Osella, Argentina
P8.047 An Arrow For Two Targets: Kidney Donation In Unilateral Renal Artery Stenosis
Mayur Patil, India
P8.048 Organ preserving cardiopulmonary resuscitation in a resource limited country to increase donor pool
Mayur Patil, India
P8.049 Treatment of chronic active antibody-mediated kidney transplant rejection with intravenous immunoglobulin
Nadzeya Rapetskaya, Belarus
P8.050 Pediatric donor transplants to adult recipients: follow-up and outcome
Manuel Rengel, Spain
P8.051 Corticosteroids withdrawal in renal grafted patients: follow-up and outcome
Manuel Rengel, Spain
P8.052 Long-term outcomes and predictors of graft function in living-donor preemptive kidney transplants.
Lúcio Requião-Moura, Brazil
P8.053 Case report: nephrotic-range proteinuria in a deceased donor recipient with acute antibody mediated rejection and familiar FSGS
Jose Otto Reusing Junior, Brazil
P8.054 Out of the box. Immunosuppressive therapy with four drugs as rescue therapy in kidney transplant recipients with chronic allograft rejection.
Wanda Rojas, Argentina
P8.055 Systemic heparinization in kidney donors during nephrectomy
Leonardo R Romeo, Argentina
P8.056 Laparoscopic managment of ureteral stricture after kidney transplantation
Leonardo R Romeo, Argentina
P8.057 Cannabidiol (CBD) oil and tacrolimus – The unexpected high in renal transplant recipients – Case series and review
Mrinalini Sarkar, United States
P8.058 Second and Third Renal Transplant During Covid 19 – A Single Center Experience in India.
Kity Sarkar, India
P8.059 Kidney transplant outcome according to pre-transplant dialysis modality
Ruben O. Schiavelli, Argentina
P8.060 Renal transplantation in the elderly. Are they all the same? A multicenter, comorbidity based study
Gervasio Soler Pujol, Argentina
P8.061 Recurrence of Membranoproliferative Glomerulonephritis After Kidney Transplantation: Risk Factors and Impact on Graft Function and Survival
Marcos Sousa, Brazil
P8.062 Prevalence of hyperkalemia (HK) among stable kidney transplant patients
Marcelo F Taylor, Argentina
P8.063 Single-cell analysis reveals immune landscape in kidney transplant recipients with antibody-mediated rejection
Puxun Tian, People's Republic of China
P8.064 Development and validation of a nomogram for remnant kidney function after living-donor donation
Puxun Tian, People's Republic of China
P8.065 Covid-19 and pediatric kidney transplantation: Iberoamerican multicentric study
Sebastián Tobia, Argentina
P8.066 Effect of renal pre-transplant desensitization on renal graft function and survival at 1 and 3 years
Lionel Cristian Arispe Vargas Sr., Mexico
P8.069 Delayed graft function: a single center experience
Carlos J Cobeñas, Argentina
P8.069a (242.12 in Journal) The outcome of the inferior epigastric artery as a donor vessel for managing accessory renal arteries in renal transplantation: a systematic review and meta-analysis
Animesh Singla, Australia
P8.070 A Case Report: HLA Antibodies in Temporal Relation to Vaccination in an End-Stage Renal Disease Pediatric Patient on the Renal Transplant Waiting List
Nidia E. Gomez, Paraguay
P8.071 Outcomes In Kidney Transplant Recipients With Allograft Failure Who Return To Dialysis
Lauren Arena, Canada
P8.072 Sex differences in acute kidney injury following BD - an isolated rat organ perfusion model
Roberto Armstrong Junior, Brazil
P8.073 (240.7 in Journal) Macrophages and different subtypes infiltrated in kidney allografts with antibody-mediated rejection
Puxun Tian, People's Republic of China
P8.074 (342.5 in journal) Risk Stratification for Kidney Transplant Recipients: a Single-Center Study
Puxun Tian, People's Republic of China
P8.075 Changes in the kidney allocation model in Uruguay - HLA compatibility vs. time on waiting list
Adriana Tiscornia, Uruguay
P8.076 (240.11 in Journal) Effect of mycophenolic acid and tacrolimus on the incidence of infectious complications after kidney transplantation
Matej Vnučák, Slovakia (Slovak Republic)
P8.078 Serial plasma exchange is a promising effective method in blood hemagglutinin level reduction
Shaimaa Z Abdelmegied, Egypt
P8.079 Systematic review and meta-analysis on the effect of blood transfusions on kidney transplant outcomes: shining new light on an age-old debate
Nauman N Ahmed, Australia
P8.080 Prevalence of new onset diabetes after transplantation in native Africans.
Ihab A M Ahmed, Sudan
P8.081 Differential control of systolic and diastolic blood pressure in renal transplant recipients
Nayef Mohammad Alawadh, Saudi Arabia
P8.082 Incidence and associated factors with uncontrolled hypertension at 12- months post-renal transplantation
Nayef Mohammad Alawadh, Saudi Arabia
P8.084 Renal Transplantation And Statins Effects On Dyslipidemia In Renal Transplant Recipients
Abdullah A Alghamdi, Saudi Arabia
P8.085 Outcomes of Post Kidney Transplant Lymphoproliferative Disorder (PTLD)
Fatima AlKindi, United Arab Emirates
P8.087 Semaglutide May be Safe after Kidney Transplant
Nizar Attallah, United Arab Emirates
P8.088 Mid term evolution of the glomerular filtration rate in living kidney donors
Tatiana Baltesova, Slovakia (Slovak Republic)
P8.092 Conversion from MPA twice a day to MPA once a day following kidney and pancreas/kidney transplantation
Diego Cantarovich, France
P8.093 ABO incompatible renal transplantation in Argentina: experience in a tertiary referral university hospital
Carlos Raúl Chiurchiu, Argentina
P8.094 Assessment of urinary tract infections microbiologically in kidney transplant recipients
Nuran Sari, Turkey
P8.095 Rasch Validation of the Psychosocial Assessment of Candidate Transplant Scale for Patients on Waitlist Deceased Donor Kidney Transplantation in South Korea
Hye Jin Chong, Korea
P8.096 Adaptation Process after Kidney Transplantation in Korean Elderly recipients: A Qualitative Study
Hye Jin Chong, Korea
P8.097 Patient experience of the kidney transplant waitlist: An Australian cohort study
Nicole L De La Mata, Australia
P8.098 Surveying the quality of life and its dimensions among kidney recipient patients referred to the sina organ procurement unit In 2021
Sanaz Dehghani, Iran (Islamic Republic of)
P8.099 Post-operative myocardial infarction after renal transplant: setback or disaster?
Joanne Devlin, United Kingdom
P8.100 Transplant in times of the beginning of SARS-coV2 pandemic, experience in reference center public hospital in Mexico
Luis Garcia Sr., Mexico
P8.101 Is pregnancy possible in kidney transplant patients? Experience in a reference center in Mexico.
Aldo Garcia C., Mexico
P8.102 Teratoma in transplanted patient, case report and review
Aldo Garcia C., Mexico
P8.103 Main clinical outcomes in living-donor kidney transplantation: A Latin-American cohort.
Fernando Giron, Colombia
P8.104 Main outcomes of pediatric living donor kidney transplantation: A Latin-American cohort.
Fernando Giron, Colombia
P8.105 Risk factors for urologic complications after kidney transplantation and impact in graft survival
Andrea García, Colombia
P8.106 Comparison of three glomerular filtration rate estimating equations with 24-hour urine creatinine clearance measurement in live kidney donors
Andrea García, Colombia
P8.107 Predicting 5-year survival after kidney transplantation in Colombia
Andrea García, Colombia
P8.108 Therapeutic plasma exchange, rituximab and steroids in pediatric kidney transplant recipients with early recurrence of FSGS: a single large pediatric hospital experience
Maya Guhan, United States
P8.109 Simultaneous vascular and antibody-mediated rejection (AMR) in pediatric patients caused poor prognosis in renal allograft
Alev Ok Atılgan, Turkey
P8.110 The beneficial impact of D3 vitamin on the decline of rejection, epithelial-mesenchymal transition (EMT), and interstitial fibrosis among pediatric renal transplant patients
Eda Yilmaz Akcay, Turkey
P8.111 Epstein-Barr virus-positive T-cell lymphoma characterized by intestinal involvement with multiple perforation in an adult renal allograft recipient: two case reports
Pelin Borcek, Turkey
P8.112 Pregnancy outcomes in kidney transplant recipients and their newborns
Burak Sayin, Turkey
P8.113 Starting a new life thanks to a successful kidney transplant after 30 years of hemodialysis: Case report
Burak Sayin, Turkey
P8.115 Polyomavirus infection in the urine for follow-up of renal transplant patient: a single center study
Ho Trung Hieu, Viet Nam
P8.118 Effect of Donor vs Recipient Delta of Age and BMI on Kidney Transplantation Outcome
Emanuele Federico Kauffmann, Italy
P8.119 Simultaneous Pancreas-Dual Kidney Transplantation: a case report
Emanuele Federico Kauffmann, Italy
P8.120 Impact of desensitization in immunological low-risk patients in kidney transplantation
Youngmin Ko, Korea
P8.121 Inguinal herniation after kidney transplantation
Takashi Kobayashi, Japan
P8.122 Tacrolimus dose reduction as an effective therapeutic approach to the patients with active BK virus replication and nephrotoxicity
Karel Krejčí, Czech Republic
P8.123 A retrospective comparison of ABO incompatible with ABO compatible and Cadaveric renal transplant, single centre experience .
Janmejay A Kunpara, India
P8.124 Recurrence of focal segmental glomerulosclerosis after kidney transplantation according to pre-transplant treatment
Hye Eun Kwon, Korea
P8.125 Anti-thymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: Matched analysis with Korean multicentric registry
Jun Young Lee, Korea
P8.126 Angiotomography in the vascular assessment of recipients before renal transplantation: a profile of excluded patients
Marcos Sousa, Brazil
P8.127 Risk factors for chronic allograft rejection after kidney transplantation: a systematic review and meta-analysis
Gede Wira Mahadita, Indonesia
P8.128 Results of a non-restrictive acceptability policy for kidney transplantation in patients with HLA sensitization
Lucila Martin Rollan, Argentina
P8.129 Description of the process of inclusion and kidney transplantation waiting list - Uruguay
Sebastián Marton, Uruguay
P8.130 Assessing Patient-Level Predictors of Obesity for Kidney Patients Referred for PreTransplant Evaluation
Terri Menser, United States
P8.131 Kidney removal from the living donor-technique and evaluation: study on 256 samples
Karim Meskouri, Algeria
P8.132 Living kidney-donation: is the donator sheltered from cardiovascular risk factors?
Malek Mojaat, Tunisia
P8.133 Metabolic outcomes still occur, but Kidney donation is obviously safe
Malek Mojaat, Tunisia
P8.134 Advanced cancers treated with PD-L1 inhibitors and CTLA-4 antagonist in transplanted immunosuppressed patients: systematic review of graft outcome
Marika Morabito, Italy
P8.135 Machine learning in kidney transplantation: a new possibility for the graft survival prediction
Marika Morabito, Italy
P8.136 Treatment of calcifying uremic arteriopathy in a renal transplant service
Liliana Miriam Obregon, Argentina
P8.137 Bladder evaluation in transplant patients : Are we overdoing it ?
Sujata Kiran Patwardhan, India
P8.138 Kidney graft survival in pediatric patients at the UMAE Pediatric Hospital of CMNO
Gabriela Esperanza Esperanza Pedroza Orozco, Mexico
P8.139 Progression of chronic kidney disease in pediatric patient with kidney transplantation
Laura K. Pineda, Argentina
P8.140 Pregnancy Outcomes After Renal Transplantation. Two-year follow-up
Johanna Caldano, Argentina
P8.141 Prevalence and outcome of kidney transplant recipients infected with BK Polyoma virus at National Kidney and Transplant Institute from 2016 to 2021
Angelo R. Rocafort, Philippines
P8.142 Perturbations in podocyte transcriptome and biological pathways induced by injury caused by FSGS associated circulating factors
Tara Sigdel, United States
P8.143 Assessment of renal allograft function via urine-based estimation of glomerular filtration rate
Tara Sigdel, United States
P8.144 Regulatory T Cell Populations May Be Associated With Transplant Outcomes
Ho Sik Shin, Korea
P8.145 Patient reported outcomes following renal transplantation: the future of holistic post-transplant care
Harry VM Spiers, United Kingdom
P8.146 Early and Late-Onset Cytomegalovirus Infection Following Universal Prophylaxis in Kidney Transplant Recipients: Risk Factors and Outcome
Matthew Tavakol, United States
P8.147 Predictors of metabolic syndrome following one-year post kidney transplantation among Vietnamese patients
Nguyen Thu Ha, Viet Nam
P8.148 HLA desensitization in kidney transplantation
Aida Turganbekova, Kazakhstan
P8.149 Development of post-transplant malignancy in kidney transplant recipients
Kalliopi Vallianou, Greece
P8.151 Serum Klotho and FGF-23 levels and their variability within two years after kidney transplantation
Teresa Vazquez Sanchez, Spain
P8.152 Clinical characteristics and factors related to recurrent cytomegalovirus infection post-kidney transplant in adult patients at Cho Ray hospital
Tho Ngoc Anh Vo, Viet Nam
P8.153 Confirmatory factor analysis of the Chinese version of self-management support scale for kidney transplant recipients
Changyun Wei, People's Republic of China
P8.154 A nomogram for predicting BK virus activation in kidney transplantation recipients using clinical risk factors
Cheng Yang, People's Republic of China
P8.155 Current trends in anemia treatment in kidney transplant recipients
Anete Granovska, Latvia
P8.156 The unfavorable influence of oral health on pre-kidney-transplant patients' quality of life
Paulo S da Silva Santos, Brazil
Poster Session: Liver
P9.01 Impact of the pandemic on liver transplantation and use of telemedicine – clinical hospital UNICAMP
Ilka FSF Boin, Brazil
P9.02 Percutaneous transhepatic TIPS for Budd-Chiari syndrome as a bridge to liver transplantation
Fatih Boyvat, Turkey
P9.03 Epidemiology of patients with Hepatocellular Carcinoma in a universitary hospital during a 12-year period: a cohort study
Francisco Maria Calderon Novoa, Argentina
P9.04 Evaluation of Quality of Life in Adult Patients after One Year Liver Transplantation
Jose Gabriel Cervantes, Argentina
P9.05 Biliary complications following liver transplantation: A 13-Years Single-center experience
Maria Florencia Fernandez, Argentina
P9.06 Liver transplantation for treatment of acute liver failure after COVID 19 infection and anatomopathological results
Guilherme Ferrarini, Brazil
P9.07 Post Liver Transplantation Renal Impairment: Experience with the First 100 cases in a Single Center in Mongolia
Angel Flores-Huidobro Martinez, United States
P9.08a (346.7 in Journal) Liver Biopsy in a clinic set up
Ruby Ann Labayo Recaido, Saudi Arabia
P9.09 Peri-hepatic gauze packing for the control of haemorrhage during liver transplantation: experience of a high-volume center
Rodrigo A. Gasque MD, Argentina
P9.10 Mono-maintenance therapy with anti-ICAM-1 monoclonal antibody induced long-term liver allograft survival in nonhuman primates
Dongkyu Han, Korea
P9.11 Survival of liver transplant patients from 2010 to 2022 belonging to the public financing program of CUCAIBA as an institution of the Ministry of Health of Buenos Aires Argentina
Florencia Hernandez, Argentina
P9.12 The impact of the multiple bile ducts on postoperative biliary complications in living donor liver transplantation; single center experience
Doojin Kim, Korea
P9.13 Outcomes in pediatric recipients of living donor liver transplantation
Ivone Malla, Argentina
P9.14 Massive blood transfusion: risk factors and consequences
Alberto A Marcacuzco Quinto, Spain
P9.15 What about the heroes? Living donor liver outcomes, from a single Latin-American center experience between 2009-2022
Leonardo Montes Sr., Argentina
P9.16 Validating survival scores following liver re-transplantation, at a single center
Leonardo Montes Sr., Argentina
P9.17 New index for prediction of massive blood transfusion
Blanca Otero Torrón, Spain
P9.18 Decreasing therapeutic anticoagulation and bleeding in post-operative liver transplant patients: a single institution’s analysis of a prospective anticoagulation algorithm
Alexandria Tran, United States
P9.21 Future Liver Remnant Volume Ratio Less Than 30% Is Not A Contraindication To Living Donor Right Hepatectomy
P9.22 Surgical site infection in liver transplant patients: Evidence from real-world studies
Md Azharuddin, India
P9.23 Single center study on liver transplantation since 1988: expected life expectancy and affecting factors
Rengin Erdal, Turkey
P9.24 An alternative abdominal closure technique after pediatric liver transplant: Bogota-bag technique
Emre Karakaya, Turkey
P9.25 Stereotactic ablative body radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma: Başkent university experience
Ebru H. Ayvazoglu Soy, Turkey
P9.27 Different severity and disparate clinical outcomes between EAD sub-criteria and proposal of a new EAD classification after liver transplantation
Jinbo Huang, People's Republic of China
P9.28 Low intra-operative urine output is associated with the development of severe acute kidney injury and continuous renal replacement therapy requiring after liver transplantation
Jinbo Huang, People's Republic of China
P9.29 Respiratory Syncytial Virus pneumonia in a LDLT recipient transplanted for COVID 19 precipitated ACLF: managed with Ribavirin and IvIg
sorabh kapoor, India
P9.30 Salvaging small for size grafts with splenic artery embolization in living donor liver transplant: older liver may not recover
sorabh kapoor, India
P9.31 Devising bile duct anastomosis to reduce biliary complications in living donor liver transplantation at our hospital
Toshiaki Kashiwadate, Japan
P9.32 Excellent outcome quality is not dependent on a high caseload in liver transplantation
Daniela Kniepeiss, Austria
P9.33 Prevention strategies against CMV-infection after liver transplantation
Daniela Kniepeiss, Austria
P9.34 Application of mesenchymal stem cells for the treatment of liver graft dysfunction caused by chronic rejection. Case report.
Aliaksei Shcherba, Belarus
P9.35 Application of CRL-classification (J. Yan et al., 2020) principles for description of rare hepatic artery anomalies.
Aliaksei Shcherba, Belarus
P9.36 Impact and consequences of recipient Gastroduodenal Artery (GDA) ligation prior to Hepatic Artery (HA) anastomosis during Orthotopic Liver Transplantation (OLT)
Aman Kumar, United States
P9.37 Liver transplantation for Abernathy malformation (congenital absence of portal vein). A case report
Jayant Kumar, United States
P9.40 Liver transplantation for secondary hemophagocytic lymphohistiocytosis associated acute liver failure: a case report
Jing-Yi Liu, People's Republic of China
P9.41 Outcomes of live donor liver transplantation in adult patients with HPS – 10-year experience from a single centre: A retrospective analysis
Rohit Mehtani, India
P9.42 Ventral hernia repair following liver transplantation: Outcomes of repair techniques and risk factors for recurrence
Megan Melland-Smith, Canada
P9.43 Conversion surgery after radical chemotherapy using living donor liver transplantation for locally advanced unresectable perihilar cholangiocarcinoma without neoadjuvant radiation
Shigehito Miyagi, Japan
P9.44 Single-cell RNA Transcriptomics Reveals Intrahepatic Macrophage Remodeling in Hepatitis B-Related Acute-on-Chronic Liver Failure
Bo Peng, People's Republic of China
P9.45 Report of the first cases of hepatic SPLIT for liver transplantation in Peru
Jose Rivera Romani, Peru
P9.46 Transition from pediatrics to adults: how adolescents with solid organ transplantation move to adult care in a general hospital
Maria Camila Sanchez, Argentina
P9.47 FIPS score as a predictor of 30-day mortality after liver transplantation – a comparison with validated risk scores (SOFT and BAR) in a Brazilian cohort of patients.
Fabio Silveira, Brazil
P9.48 A systematic review of the use of patient-reported outcome measures (PROMs) in adults undergoing liver transplantation
Samira Elize Mariko van Knippenberg, Netherlands
P9.49 Efficacy analysis of liver transplantation and Vasomodulators therapy for portalpulmonary hypertension
Li-Na Wu, People's Republic of China
P9.50 Novel MLTR classification of portal vein thrombosis for purposes of liver transplantation
Boris I Yaremin, Russian Federation
P9.51 Single-cell RNA transcriptomics reveals dysfunction of hepatic lymphatic endothelial cells in Hepatitis B-Related Acute-on-Chronic Liver Failure
Pengpeng Zhang, People's Republic of China
P9.52 Role Of Circulating Tumour Cells In The Management Of The Liver Transplant Patient With Hepatocellular Carcinoma
Felipe Alconchel, Spain
P9.53 Clinical Relevance Of Pivka-ii After Liver Transplantation For Hepatocellular Carcinoma
Felipe Alconchel, Spain
P9.54 Graft Versus Host Disease Following Liver Transplantation. A serious complication.
Carlos W. Florez Zorrilla, Mexico
P9.55 The role of interventional radiology in the management of early vascular complications after liver transplantation
Fatih Boyvat, Turkey
Poster Session: Miscellaneous Topics
P10.01 How did the war affect organ transplantation in Syria?
Bassam Saeed, Syrian Arab Republic
P10.02 Dapsone Induced Hemolytic Anemia In Solid Organ Transplant Recipients With Normal G6PD Activity
Walaa Dabbas, United States
P10.03 Alternative surgical techniques for abdominal wall graft donation to guarantee abdominal wall closure in the donor.
Clara Fernández, Spain
P10.04 (347.10 in the Journal) Worse Graft Outcome after Pregnancy in Female Transplant Recipients
Cheng-Hsu Chen, Taiwan
Poster Session: Organ Donation and Procurement
P11.01 Increasing the consent for Brain death donor family members
Altantulga Bayaraa, Mongolia
P11.02 Application of ex-vivo normothermic machine perfusion to assess renal allograft viability following renal vein thrombosis
Ashish Sharma, India
P11.03 Access to kidney and liver transplantation in the adult and pediatric population: Interference of Argentine legislation
Carolina Gabriela Genovese, Argentina
P11.04 Evolution and impact of regional investment projects on public offer of organ procurement and transplantation in Argentina: an analysis from 2008 to 2021
Adriana Procupet Blaustein, Argentina
P11.05 Monitoring of organ donation potential from brain dead donors in Polish hospitals using web-tooled system of monitoring ICU deaths, taking into account the stratification of hospitals with the donation potential.
Teresa Danek, Poland
P11.06 HTK vs WISCONSIN and Delayed Renal Graft Function
José Emiliano Alfonso Sr., Argentina
P11.07 BMSCs combined with normothermic machine perfusion resuscitate aged donor liver with long warm ischemia time in rats
Yiwen Guo, People's Republic of China
P11.44 (247.7 in Journal) Trends and Risk Factors for Mortality While Awaiting Heart Transplantation: a UNOS Registry Analysis
Nicholas R Hess, United States
P11.08 International Registry in Organ Donation and Transplantation (IRODAT) – 2021 Worldwide data
Marian Irazabal, Spain
P11.09 New technique for the extraction of abdominal wall grafts
Iago Justo, Spain
P11.10 Changes of Brain Death Donors for recent 10 years in Korea (Based on Organ Transplantation Law)
Mina Lee, Korea
P11.11 A new designed machine perfusion system to mimic the cardiac cycle's heart function for a better hepatic microcirculation perfusion
Fan Lin, People's Republic of China
P11.12 Global and country-level growth in deceased organ donation over two decades
Yosef Manla, United Arab Emirates
P11.13 Organization of Organ and Bone Marrow Donation and Transplantation in Poland
Klaudia Nestorowicz-Kałużna, Poland
P11.14 The use of ex vivo normothermic perfusion to 'pause' cold ischaemic time to allow for third recipient to be selected and undergo kidney transplant
Robert C Pearson, United Kingdom
P11.15 DONASUR: Descriptive analysis of 11 years of Argentina's participation
Romina Perez Manelli, Argentina
P11.16 Quality monitoring indicators in the process of organ and tissue donation for transplantation: a scoping review preliminary results
Rafael Rodrigo da Silva Pimentel, Brazil
P11.17 Sustaining life after brain death during pregnancy: a case report
Marco Sacchi, Italy
P11.18 Allocating deceased donor using local vs imported renal allografts: logistics are more important than distance
Reza F Saidi, United States
P11.19 System-Level Barriers to Living Donor Kidney Transplantation: A Cross-Sectional Survey Study of Health Professionals
Shaifali Sandal, Canada
P11.20 Detailed analysis of autopsies on brain-dead organ donors
Ki Dong Song, Korea
P11.21 Appointed donor responsible doctor and donor responsible nurse increase organ transplantation in Sweden
Wenche Stribolt, Sweden
P11.24 The Korean experiences of re-use transplanted liver or kidney: case series
Eun Jin Woo, Korea
P11.25 Why do not all living kidney donor candidates are accepted for donation? A pediatric center experience
Ana B Calderón Alvarado, Mexico
P11.26 Serological profile of donors in Argentina
Marisa M. Cobos, Argentina
P11.27 Changes in markers of coagulation and fibrinolysis offer insights into pathophysiological aspects of preservation injury during normothermic liver perfusion
Jule Dingfelder, Austria
P11.28 Effect of temporal Trends in Donor Demographics on Perioperative Outcomes in Robotic Living Donor Nephrectomy
Arshad B Khan, United States
P11.29 Improving Tissue Donation referral rates from the Emergency Department - a QI project
Susan Macmillan, United Kingdom
P11.30 Influence of basic cardiopulmonary reanimation on uncontrolled donors after cardiac death
Alfonso Mateos-Rodriguez, Spain
P11.31 Gendering Organ Donation: Experiences of living women organ donors in India
Nishtha Mishra, India
P11.32 Brain death in Uruguay. 19 years of experience
Ana Castro, Uruguay
P11.33 Donation and transplantation indicators in the pre and post pandemic stage. Organ Use Rate
Agustin M Carambula Simon, Uruguay
P11.34 Tissue donation indicators in Latin American and European countries. A way to measure the efficiency of the organizational system
Raul Mizraji, Uruguay
P11.35 Using Emotional Text Mining to explore the cultural representation of organ donation in the Spanish and Italian culture
Silvia Monaco, Italy
P11.36 Indocyanine Green (ICG) Angiography for Assessing Microcirculation Patency Improvement after Hypothermic Machine Perfusion (HMP) Re-Conditioning: A Pilot Study
Marika Morabito, Italy
P11.37 A new successful training method for brain death family approach
Katayoun Najafizadeh, Iran (Islamic Republic of)
P11.38 Impact of two different TV content on promote organ donor registration
Katayoun Najafizadeh, Iran (Islamic Republic of)
P11.39 Knowledge and attitudes among health care workers in the Sri Jayawardenapura General Hospital ICU regarding organ donation: Do they know enough; a pilot study developed under the ISN-TTS STC
Chloë Ballesté, Spain
P11.40 Interstitial glucose metabolism monitoring is additional tool for objective assessment of a donor liver, prediction and immediate diagnosis of early graft dysfunction
Alexander I Sushkov, Russian Federation
P11.41 Investigation of optimal temperature for machine perfusion of liver transplantation in donors after cardiac death
Naruhito Takido, Japan
P11.42 (247.8 in Journal) Early Experience of 48-hour Normothermic Machine Perfusion in Human Kidneys Applying Urine Recirculation
Annemarie Weissenbacher, Austria
P11.43 (244.2 in Journal) 18-Year Follow-Up Of Kidney Donation In The Living Donor Transplant Program At A Reference Pediatric Hospital
Mitzi R Becerra, Mexico
Poster Session: Pancreas and Islets
P12.01 Effective treatment of diabetes, improved quality of life and accelerated cognitive development after Pancreas Transplantation in a Child with Type 1 Diabetes and Allergy to Manufactured Insulin Preparations
Anna M Adamusiak, United States
P12.02 Bionic pancreas – 3D bioprinting of a bionic organ with a vascular system – results of transplantation in large animals.
Andrzej Berman, Poland
P12.02a (241.1 in Journal) Maturation and evaluation of 3D printed bionic pancreas with a dedicated bioreactor.
Andrzej Berman, Poland
P12.03 Report of the first 70 pancreas transplant in a Latin-American Center
Maria Florencia Fernandez, Argentina
P12.04 Switch from Calcineurin Inhibitor to Belatacept in kidney-pancreas transplant recipients. Single-center retrospective study from Argentina
Sebastián Jaurretche Sr., Argentina
P12.05 Bionic Pancreas - the first results of functionality of 3D-bioprinted bionic tissue model transplantation with pancreatic islets
Andrzej Berman, Poland
P12.06 Effect of supplementing taurine to the developed low-temperature islet preservation solution
Jae-Kyung Park, Korea
P12.07 The role of pancreatic exocrine secretion in weight gain following pancreas transplantation
Michael D Williams, United States
P12.08 (241.12 in the Journal) 4-Octyl itaconate inhibits hypoxia-induced injuries on β-cell via reducing LDHA-mediated ROS generation
Jianmin Wu, People's Republic of China
P12.11 Immunomodulatory Microporous Annealed Particle (MAP) gel protects delivery of islets to promote islet transplantation outcomes.
Kenneth L. Brayman, United States
P12.12 The impact of recipient body mass index on outcomes of pancreas transplantation: A systematic review
Harry J. de Souza, Australia
P12.13 Simultaneous kidney and pancreas transplantation in patients with type 1 diabetes mellitus, almenara hospital Lima-Peru, 2009-2021
Sherley Diestra Sr., Peru
P12.14 Liver surface can be a promising transplant site for pancreatic islets using a gelatin hydrogel nonwoven fabric
Yukiko Endo, Japan
P12.15 Dapagliflozin for the treatment of Post-Transplant Diabetes Mellitus after Pancreas Transplantation: a case report with a 14-month follow-up
Alessandro Mattina, Italy
P12.16 Availability of using amnion for islet transplantation
Naoaki Sakata, Japan
P12.17 Simultaneous pancreas-kidney transplantation in one Russian transplant center
Nikita Sergeevich Zhuravel, Russian Federation
P12.18 (343.6 in Journal) Outcomes of simultaneous kidney-pancreas transplantation in patients with type-1 and type-2 diabetes mellitus
Hosein Shokouh-Amiri, United States
Poster Session: Pediatric Transplantation
P13.01 Pediatric liver transplantation for inborn errors of metabolism at the Hospital Juan P Garrahan, Argentina
V. G Bindi, Argentina
P13.02 Significant fall in living donation rates of pediatric kidney transplants in Puerto Rico
Nilka deJesus-Gonzalez, Puerto Rico
P13.03 Multidisciplinary Approach to Hepatoblastoma in Pediatric Liver Transplantation
Angel Flores-Huidobro Martinez, United States
P13.04 Association between vitamin D deficiency and anemia in pediatric renal transplant recipients
Esra Baskin, Turkey
P13.05 Probable posttransplant lymphoproliferative disorder after pediatric living donor liver transplantation: is a biopsy still needed?
Muneyuki Matsumura, Japan
P13.06 Valve bladder diversion, making possible a kidney transplant
Ramiro Perea, Argentina
P13.07 Detecting Subclinical Rejection using dd-cfDNA in Pediatric Kidney Transplant
Auda M. V. Plaud Gonzalez, Puerto Rico
P13.08 Pediatric kidney transplantation in the Middle-East: challenges and solutions
Bassam Saeed, Syrian Arab Republic
P13.09 Biliary atresia: intention-to-treat analysis in a pediatric liver transplant center
Joao Seda Neto, Brazil
P13.10 Secondary ureteral re-implantation for persistent urinary leakage following renal transplantation in a Nigerian pediatric patient: A case report.
Olalekan O. Olatise, Nigeria
P13.11 The largest single center report on hypertyrosinemia and liver transplantation
Seyed Ali Malek Hosseini, Iran (Islamic Republic of)
P13.12 (243.12 in the Journal) A mixed-method systematic review examining the effects of digital behaviour change interventions (DBCIs) focussing on improving medication adherence in adolescent and young adult kidney transplant patients.
Akanksha Singh, United Kingdom
P13.13 Pediatric Transplant and SARS Cov2 in a Country with high lethality.
Luciola Vasquez, Peru
P13.14 Liver Transplantation in Alagille Syndrome with NOTCH2 genetic variant. Case Report
Luciola Vasquez, Peru
P13.15 Experience in Pediatric Renal Transplantation. Guillermo Almenara Irigoyen National Hospital- Lima, Peru. 2009 - 2021
Luciola Vasquez, Peru
P13.16 Experience in a COVID19 nephrology center and pediatric kidney transplant
Gabriela Gutiérrez Garcete, Paraguay
P13.17 Clinical features and outcomes following SARS-cov-2 infection in pediatric liver transplant patients
Figen Ozcay, Turkey
P13.18 Our pediatric liver and kidney transplant activities in 2021
Emre Karakaya, Turkey
P13.19 Decrease incidence of typical hemolytic uremic syndrome as a cause for kidney transplantation in children at Garrahan hospital
Natalia Panero, Argentina
P13.20 A digital self-management platform for adolescent and young adult patients who have undergone a kidney transplant: A qualitative study with co-production activities.
Akanksha Singh, United Kingdom
Poster Session: Thoracic
P14.01 Cryobiopsy in the diagnosis of lung allograft rejection : Brazilian case series.
Carlos E Belon, Brazil
P14.02 Viability of native kidney in cardiorenal transplantation
Rosario Della Cella Figueredo, Argentina
P14.03 The usefulness of non-HLA monitoring during graft rejection surveillance in heart transplantation
Olga L. Vanco, Argentina
P14.04 Lung transplant: supply or demand problem? Description of real donor patients in a Public Hospital of the Argentine Republic
Daniel A Rodriguez Lic., Argentina
P14.05 Prone position: a measure of lung protection in potential lung donors. Case report
Daniel A Rodriguez Lic., Argentina
P14.06 Lung procurement: Inclusion of modern variables to assess its quality. Descriptive study in a Public Hospital of the Argentine Republic
Daniel A Rodriguez Lic., Argentina
P14.07 Use of grafts with extended ischemic time (above 4 hours or more): analysis of the experience of the largest Brazilian heart transplant center, from 2013 to 2022.
Ronaldo Honorato Barros Santos, Brazil
P14.08 Outcomes of heart failure patients excluded from heart transplant waiting list
Maria Simonenko, Russian Federation
P14.09 Donor-derived cell free DNA is associated with antibody-mediated rejection and impaired cardiac hemodynamics in patients with heart transplantation
Giosafat Spitaleri, Italy
P14.10 Heart transplant quilty lesions are associated with an immunologic tolerant profile
Jose R Torrealba, United States
P14.11 Lung transplantation in adult patients with bronchiectasis
Esteban Wainstein, Argentina
P14.14 The experience of physical activities in lung transplant recipients:a qualitative study
Wang Ruiting, Taiwan
P14.15 Early preventive “coronary sealing” of transmitted coronary artery disease with stent PTCA to improve outcomes of heart transplantation
Alex O Shevchenko, Russian Federation
P14.16 Acute and chronic allograft rejection in the uruguayan lung transplant program in the 2003 – 2022 period
Isabel Villanueva, Uruguay
Poster Session: Transplant Immunosuppression
P15.01 Posterior reversible encephalopathy syndrome in transplant patients: diagnosis and management
Aydincan Akdur, Turkey
P15.02 (245.12 in the Journal) 4-Octyl itaconate inhibits T cells’ proliferation and aerobic glycolysis to prevent immune over activation
Yao Deng, People's Republic of China
P15.03 Granulocyte colony-stimulating factor with or without immunosuppression reduction in neutropenic kidney transplant recipients
Shaifali Sandal, Canada
P15.04 Human Primary Renal Tubuloids as Tools for Calcineurin inhibitor Nephrotoxicity Assessment
Puxun Tian, People's Republic of China
P15.05 Safety of once-weekly dulaglutide on post-transplant diabetes mellitus: a preliminary single-centre experience
Alessandro Mattina, Italy
P15.06 Distinct FOXP3 gene expression in the peripheral blood and inside renal allografts is associated with use of mTOR inhibitors and extended criteria kidney donor
Mario Abbud-Filho Sr., Brazil
P15.07 Risk prediction model for immunosuppressive medication nonadherence in kidney transplantation recipients
Lei Dong, People's Republic of China
P15.08 Effects of bcl-6 inhibition on the humoral alloresponse
Rens Kraaijeveld, Netherlands
P15.09 Determination of tacrolimus dosage using machine learning in kidney transplantation
Sangkyun Mok, Korea
P15.10 The impact of different induction immunosuppression protocol on patient survival, graft survival and acute graft rejection after kidney transplantation – multicenter study
Matej Vnučák, Slovakia (Slovak Republic)
Poster Session: Transplant Infectious Diseases and Covid-19
P16.01 Decreased mortality from SARS-coV-2 infection in kidney transplant recipients over the course of the pandemic
Enver Akalin, United States
P16.02 Safety and effectiveness of Covid-19 vaccination in the islet transplant recipients
Mateusz Ogledzinski, United States
P16.03 Argentine COVID 19 Registry transplantation: A national cohort study
Liliana Bisigniano MD, Argentina
P16.04 Seroprevalence of SARS-CoV-2 antibodies following vaccination amongst renal transplant recipients: A single centre-experience
John Black, United Kingdom
P16.05 Adaptative strategies implemented by an OPO in argentina for the protection of transplant patients and the OPO's own staff in the context of the SARS-coV-2 pandemic
Graciela G Bosch B, Argentina
P16.06 Seroconversion in pacients after SARS-cov-2 ChAdOx1 nCoV-19/AZD1222 vaccination in hemodialysis patients and kidney transplant recipients
Alfredo Chew-Wong, Mexico
P16.07 Association Between SARS-CoV-2 Infection and De Novo HLA Donor Specific Antibody Production in Lung Transplant Recipients: Single-center study
Mohamed Elrefaei, United States
P16.08 Covid-19 positive kidney transplant recipients behave differently compared to non-transplant patients ICU: single center experience
Osama Ashry Gheith, Egypt
P16.09 Spectrum of side effects of mRNA COVID-19 vaccine among Asian kidney transplant recipients and healthcare providers at the Singapore General Hospital
Terence Kee, Singapore
P16.10 SARS-CoV-2 vaccination in liver transplant recipients
Daniela Kniepeiss, Austria
P16.11 Decreased immunogenicity after SARS-CoV-2 vaccination in liver and kidney transplant recipients
Jae Hyun Kwon, Korea
P16.12 Mortality in patients on dialyses and kidney transplant recipients during pandemic
Jolanta Malyszko, Poland
P16.13 Covid-19 infection in kidney transplant recipients from the IPS: evolution of kidney function and complications
Adriana Carolina C Martínez Cortti Sr., Paraguay
P16.14 Impact of vaccination against Covid 19 in the population of intrathoracic transplant recipients during the pandemic
Ludmila Morcos, Argentina
P16.15 HLA genetic frequency in Renal Transplantation Patients, dead by covid-19
Gustavo Piccinelli, Argentina
P16.16 Seroconversion in liver and intestine transplant patients after one, two or three doses of adenoviral vector vaccines against SARS-CoV-2. Single center experience in Argentina
Martin Rumbo, Argentina
P16.17 Analyzing the impact of the COVID-19 pandemic on communication and education strategies across transplant programs in Canada
Shaifali Sandal, Canada
P16.18 Behavior of anti- SARS-CoV-2 antibodies in renal transplant patients vaccinated prior to transplantation
Ruben O. Schiavelli, Argentina
P16.19 Omicron COVID-19 in Kidney Transplant Recipients
Gisela Serra Rodrigues Costa, Brazil
P16.21 Impact of vaccination against SARS CoV2 in kidney transplant recipients
Marcelo F Taylor, Argentina
P16.22 Graft and patients’ outcome in kidney and simultaneous liver-kidney transplantation with infection control measures and immune suppression adjustment during COVID-19 era
Shaimaa Z Abdelmegied, Egypt
P16.23 Antibody response to SARS-CoV-2 mRNA vaccine in kidney transplant recipients
Ali B. Mahgoub, Qatar
P16.25 Immunoglobulin M (IgM) delays disease in K18-hACE2 mice infected with SARS-CoV-2
Kenneth L. Brayman, United States
P16.26 Adenosine A2A receptor (A2AR) agonists improve survival in K28-hACE2 mice and Syrian hamsters following SARS CoV-2 infection
Kenneth L. Brayman, United States
P16.27 A Case of Cytomegalovirus (CMV) Esophagitis Without CMV Viremia After SARS-CoV-2 Infection In A Kidney Transplant Recipient While on CMV Prophylaxis
Walaa Dabbas, United States
P16.29 Clinical profile and outcomes of COVID 19 among renal transplant recipients across three waves of SARS CoV2 infection: A multicenter study from South India
Jeethu Joseph Eapen, India
P16.30 Assessment of the impact of the COVID -19 pandemic on the number of brain deaths, family donations, and organs used between 2019-2020 in the Bursa regional coordination center with the most donors in Turkey
Mehmet Sezen, Turkey
P16.31 COVID-19 infection in kidney transplant patients in a Colombian cohort
Jessica JL Pinto Ramirez PR, Colombia
P16.32 COVID-19 clinical outcomes, coinfection and secondary infections in solid organ transplant recipients
Tugba Yanik Yalcin, Turkey
P16.33 Comparison of kidney transplant outcomes before and after Coronavirus Disease 2019 pandemic : a single-institution experience
Yang-Wook Kim, Korea
P16.34 Native kidney infection due to non-tuberculous mycobacteria diagnosed by molecular multiplex test in renal transplant: a case report
Lucila Martin Rollan, Argentina
P16.35 Pandemic research in organ transplantation from India
Hari Shankar Meshram, India
P16.36 Effectiveness of SARS-cov 2 vaccination in kidney transplant patients in Chile
Jaqueline Pefaur Penna, Chile
P16.37 Outcomes of COVID-19 vaccination among Kidney Transplant Recipients admitted for COVID-19 at the National Kidney and Transplant Institute: A Retrospective Study
Fern Lyse Q. Peñaranda, Philippines
P16.38 Healthcare resource utilization in transplant recipients with cytomegalovirus infection refractory to prior treatment with/without resistance receiving maribavir versus investigator-assigned therapy: Exploratory analysis of the Phase 3 SOLSTICE trial
Ishan Hirji, United States
P16.39 Immunogenicity of the inactivated SARS-CoV-2 vaccine (BBIBP-CorV; Sinopharm) and short term clinical outcomes in vaccinated solid organ transplant recipients: a prospective cohort study
Mojtaba Shafiekhani, Iran (Islamic Republic of)
P16.40 Physicians’ opinions regarding low-level Epstein-Barr virus DNA levels from PCR testing
Akos Somoskovi, United States
P16.41 Acute kidney rejection after anti-sars-cov-2 virus-vectored vaccine – case report
Matej Vnučák, Slovakia (Slovak Republic)
P16.42 (248.12 in the Journal) Critically important outcomes for infection in trials in kidney transplantation: an international survey of patients, caregivers and health professionals
Samuel Chan, Australia
Poster Session: Xenotransplantation / Cell and Tissue Banking
P17.01 Bioink based on the dECM for 3D-bioprinting of bionic tissue - first results obtained on murine model
Andrzej Berman, Poland
P17.02 Towards bionic organs: biocompatibility of newly developed porcine dECM-based hydrogels
Andrzej Berman, Poland
P17.03 Quadruple KO porcine adult pancreatic islet induced long-term xenograft survival in diabetic mice
Kyungmin Kwak, Korea
P17.04 Feasibility and safety of intravenous infusion of autologous Umbilical Cord Blood for newborns with perinatal Hypoxic-Ischemic Encephalopathy: Argentina´s experience
Cecilia Gamba, Argentina
P17.05 Comparison of laboratory- and clinical-grade reagents in isolation and cultivation of human amniotic epithelial cells
Chika Takano, Japan
P17.06 Escape from macrophage-mediated rejection by human surfactant protein (SP) -A
Chiyoshi Toyama, Japan
P17.07 Comparison of graft survival between full thickness and lamellar pig-to-monkey corneal xenotransplantation from the same genetically engineered pig with minimal immunosuppression.
Ik Jin Yun, Korea
P17.08 Study of umbilical mesenchymal stem cells derived exosomes in enhancing UCB-Treg immune-suppressive function after adoptive transfer in X-GVHD model mice
Juan Zhang, People's Republic of China
P17.09 CD27-expressing xenoantigen-expanded human regulatory T cells are efficient in suppressing xenogeneic immune response
Lu Cao, People's Republic of China
P17.10 Effect of factor H on complement alternative pathway activation in human serum remains on porcine cells lacking N-glycolylneuraminic acid
Hee Jung Kang, Korea
© 2024 TTS 2022